Cargando…

Extraintestinal Manifestations of Inflammatory Bowel Disease

Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with IBD significantly requiring specific treatment depending on the affected organ(s). They most frequently affect joint...

Descripción completa

Detalles Bibliográficos
Autores principales: Vavricka, Stephan R., Schoepfer, Alain, Scharl, Michael, Lakatos, Peter L., Navarini, Alexander, Rogler, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511685/
https://www.ncbi.nlm.nih.gov/pubmed/26154136
http://dx.doi.org/10.1097/MIB.0000000000000392
_version_ 1782382379491393536
author Vavricka, Stephan R.
Schoepfer, Alain
Scharl, Michael
Lakatos, Peter L.
Navarini, Alexander
Rogler, Gerhard
author_facet Vavricka, Stephan R.
Schoepfer, Alain
Scharl, Michael
Lakatos, Peter L.
Navarini, Alexander
Rogler, Gerhard
author_sort Vavricka, Stephan R.
collection PubMed
description Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with IBD significantly requiring specific treatment depending on the affected organ(s). They most frequently affect joints, skin, or eyes, but can also less frequently involve other organs such as liver, lungs, or pancreas. Certain EIM, such as peripheral arthritis, oral aphthous ulcers, episcleritis, or erythema nodosum, are frequently associated with active intestinal inflammation and usually improve by treatment of the intestinal activity. Other EIM, such as uveitis or ankylosing spondylitis, usually occur independent of intestinal inflammatory activity. For other not so rare EIM, such as pyoderma gangrenosum and primary sclerosing cholangitis, the association with the activity of the underlying IBD is unclear. Successful therapy of EIM is essential for improving quality of life of patients with IBD. Besides other options, tumor necrosis factor antibody therapy is an important therapy for EIM in patients with IBD.
format Online
Article
Text
id pubmed-4511685
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-45116852015-08-03 Extraintestinal Manifestations of Inflammatory Bowel Disease Vavricka, Stephan R. Schoepfer, Alain Scharl, Michael Lakatos, Peter L. Navarini, Alexander Rogler, Gerhard Inflamm Bowel Dis Clinical Review Articles Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with IBD significantly requiring specific treatment depending on the affected organ(s). They most frequently affect joints, skin, or eyes, but can also less frequently involve other organs such as liver, lungs, or pancreas. Certain EIM, such as peripheral arthritis, oral aphthous ulcers, episcleritis, or erythema nodosum, are frequently associated with active intestinal inflammation and usually improve by treatment of the intestinal activity. Other EIM, such as uveitis or ankylosing spondylitis, usually occur independent of intestinal inflammatory activity. For other not so rare EIM, such as pyoderma gangrenosum and primary sclerosing cholangitis, the association with the activity of the underlying IBD is unclear. Successful therapy of EIM is essential for improving quality of life of patients with IBD. Besides other options, tumor necrosis factor antibody therapy is an important therapy for EIM in patients with IBD. Lippincott Williams & Wilkins 2015-07-02 2015-08 /pmc/articles/PMC4511685/ /pubmed/26154136 http://dx.doi.org/10.1097/MIB.0000000000000392 Text en Copyright © 2015 Crohn's & Colitis Foundation of America, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Review Articles
Vavricka, Stephan R.
Schoepfer, Alain
Scharl, Michael
Lakatos, Peter L.
Navarini, Alexander
Rogler, Gerhard
Extraintestinal Manifestations of Inflammatory Bowel Disease
title Extraintestinal Manifestations of Inflammatory Bowel Disease
title_full Extraintestinal Manifestations of Inflammatory Bowel Disease
title_fullStr Extraintestinal Manifestations of Inflammatory Bowel Disease
title_full_unstemmed Extraintestinal Manifestations of Inflammatory Bowel Disease
title_short Extraintestinal Manifestations of Inflammatory Bowel Disease
title_sort extraintestinal manifestations of inflammatory bowel disease
topic Clinical Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511685/
https://www.ncbi.nlm.nih.gov/pubmed/26154136
http://dx.doi.org/10.1097/MIB.0000000000000392
work_keys_str_mv AT vavrickastephanr extraintestinalmanifestationsofinflammatoryboweldisease
AT schoepferalain extraintestinalmanifestationsofinflammatoryboweldisease
AT scharlmichael extraintestinalmanifestationsofinflammatoryboweldisease
AT lakatospeterl extraintestinalmanifestationsofinflammatoryboweldisease
AT navarinialexander extraintestinalmanifestationsofinflammatoryboweldisease
AT roglergerhard extraintestinalmanifestationsofinflammatoryboweldisease